Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 69

1.

Empagliflozin Improves Diastolic Function in a Nondiabetic Rodent Model of Heart Failure With Preserved Ejection Fraction.

Connelly KA, Zhang Y, Visram A, Advani A, Batchu SN, Desjardins JF, Thai K, Gilbert RE.

JACC Basic Transl Sci. 2019 Feb 25;4(1):27-37. doi: 10.1016/j.jacbts.2018.11.010. eCollection 2019 Feb.

2.

Renal Hemodynamic Function and RAAS Activation Over the Natural History of Type 1 Diabetes.

Lytvyn Y, Bjornstad P, Lovshin JA, Boulet G, Farooqi MA, Lai V, Tse J, Cham L, Lovblom LE, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Advani A, Sochett E, Perkins BA, Cherney DZI.

Am J Kidney Dis. 2019 Feb 22. pii: S0272-6386(19)30044-7. doi: 10.1053/j.ajkd.2018.12.034. [Epub ahead of print]

PMID:
30799029
3.

Association between uric acid, renal haemodynamics and arterial stiffness over the natural history of type 1 diabetes.

Lytvyn Y, Bjornstad P, Lovshin JA, Singh SK, Boulet G, Farooqi MA, Lai V, Tse J, Cham L, Lovblom LE, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Advani A, Sochett E, Perkins BA, Cherney DZI.

Diabetes Obes Metab. 2019 Jun;21(6):1388-1398. doi: 10.1111/dom.13665. Epub 2019 Mar 28.

PMID:
30761725
4.

Histone H3 Serine 10 Phosphorylation Facilitates Endothelial Activation in Diabetic Kidney Disease.

Alghamdi TA, Batchu SN, Hadden MJ, Yerra VG, Liu Y, Bowskill BB, Advani SL, Geldenhuys L, Siddiqi FS, Majumder S, Advani A.

Diabetes. 2018 Dec;67(12):2668-2681. doi: 10.2337/db18-0124. Epub 2018 Sep 13.

PMID:
30213824
5.

Histone Deacetylase Inhibitors and Diabetic Kidney Disease.

Hadden MJ, Advani A.

Int J Mol Sci. 2018 Sep 5;19(9). pii: E2630. doi: 10.3390/ijms19092630. Review.

6.

The Dipeptidyl Peptidase 4 Substrate CXCL12 Has Opposing Cardiac Effects in Young Mice and Aged Diabetic Mice Mediated by Ca2+ Flux and Phosphoinositide 3-Kinase γ.

Batchu SN, Thieme K, Zadeh FH, Alghamdi TA, Yerra VG, Hadden MJ, Majumder S, Kabir MG, Bowskill BB, Ladha D, Gramolini AO, Connelly KA, Advani A.

Diabetes. 2018 Nov;67(11):2443-2455. doi: 10.2337/db18-0410. Epub 2018 Aug 27.

7.

Histones and heart failure in diabetes.

Yerra VG, Advani A.

Cell Mol Life Sci. 2018 Sep;75(17):3193-3213. doi: 10.1007/s00018-018-2857-1. Epub 2018 Jun 22. Review.

8.

Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2/3 transactivation.

Bugyei-Twum A, Ford C, Civitarese R, Seegobin J, Advani SL, Desjardins JF, Kabir G, Zhang Y, Mitchell M, Switzer J, Thai K, Shen V, Abadeh A, Singh KK, Billia F, Advani A, Gilbert RE, Connelly KA.

Cardiovasc Res. 2018 Oct 1;114(12):1629-1641. doi: 10.1093/cvr/cvy131.

PMID:
29800064
9.

HDAC6 Inhibition Promotes Transcription Factor EB Activation and Is Protective in Experimental Kidney Disease.

Brijmohan AS, Batchu SN, Majumder S, Alghamdi TA, Thieme K, McGaugh S, Liu Y, Advani SL, Bowskill BB, Kabir MG, Geldenhuys L, Siddiqi FS, Advani A.

Front Pharmacol. 2018 Feb 1;9:34. doi: 10.3389/fphar.2018.00034. eCollection 2018.

10.

Shifts in podocyte histone H3K27me3 regulate mouse and human glomerular disease.

Majumder S, Thieme K, Batchu SN, Alghamdi TA, Bowskill BB, Kabir MG, Liu Y, Advani SL, White KE, Geldenhuys L, Tennankore KK, Poyah P, Siddiqi FS, Advani A.

J Clin Invest. 2018 Jan 2;128(1):483-499. doi: 10.1172/JCI95946. Epub 2017 Dec 11.

11.

Dapagliflozin in focal segmental glomerulosclerosis: a combined human-rodent pilot study.

Rajasekeran H, Reich HN, Hladunewich MA, Cattran D, Lovshin JA, Lytvyn Y, Bjornstad P, Lai V, Tse J, Cham L, Majumder S, Bowskill BB, Kabir MG, Advani SL, Gibson IW, Sood MM, Advani A, Cherney DZI.

Am J Physiol Renal Physiol. 2018 Mar 1;314(3):F412-F422. doi: 10.1152/ajprenal.00445.2017. Epub 2017 Nov 15.

12.

Liraglutide and Renal Outcomes in Type 2 Diabetes.

Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators.

N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011.

13.

EP4 inhibition attenuates the development of diabetic and non-diabetic experimental kidney disease.

Thieme K, Majumder S, Brijmohan AS, Batchu SN, Bowskill BB, Alghamdi TA, Advani SL, Kabir MG, Liu Y, Advani A.

Sci Rep. 2017 Jun 13;7(1):3442. doi: 10.1038/s41598-017-03237-3.

14.

Janus Kinase 2 Regulates Transcription Factor EB Expression and Autophagy Completion in Glomerular Podocytes.

Alghamdi TA, Majumder S, Thieme K, Batchu SN, White KE, Liu Y, Brijmohan AS, Bowskill BB, Advani SL, Woo M, Advani A.

J Am Soc Nephrol. 2017 Sep;28(9):2641-2653. doi: 10.1681/ASN.2016111208. Epub 2017 Apr 19.

15.

Renal and Vascular Effects of Uric Acid Lowering in Normouricemic Patients With Uncomplicated Type 1 Diabetes.

Lytvyn Y, Har R, Locke A, Lai V, Fong D, Advani A, Perkins BA, Cherney DZI.

Diabetes. 2017 Jul;66(7):1939-1949. doi: 10.2337/db17-0168. Epub 2017 Apr 13.

16.

Urinary adenosine excretion in type 1 diabetes.

Rajasekeran H, Lytvyn Y, Bozovic A, Lovshin JA, Diamandis E, Cattran D, Husain M, Perkins BA, Advani A, Reich HN, Kulasingam V, Cherney DZI.

Am J Physiol Renal Physiol. 2017 Aug 1;313(2):F184-F191. doi: 10.1152/ajprenal.00043.2017. Epub 2017 Apr 5.

17.

VEGF and the diabetic kidney: More than too much of a good thing.

Majumder S, Advani A.

J Diabetes Complications. 2017 Jan;31(1):273-279. doi: 10.1016/j.jdiacomp.2016.10.020. Epub 2016 Oct 22. Review.

PMID:
27836681
18.

Diabetes in Emerging Adulthood: Transitions Lost in Translation.

Markowitz B, Parsons JA, Advani A.

Can J Diabetes. 2017 Feb;41(1):1-5. doi: 10.1016/j.jcjd.2016.06.004. Epub 2016 Sep 19. No abstract available.

PMID:
27658766
19.

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbøll T; SUSTAIN-6 Investigators.

N Engl J Med. 2016 Nov 10;375(19):1834-1844. Epub 2016 Sep 15.

20.

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators.

N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13.

Supplemental Content

Loading ...
Support Center